Literature DB >> 17703297

Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coli.

Sehoon Kim1, Lawrence H Cheung, Weihe Zhang, Michael G Rosenblum.   

Abstract

The immunocytokine scFvMEL/TNF is a fusion protein composed of tumor necrosis factor (TNF-alpha) and a single-chain Fv antibody scFvMEL targeting the melanoma-associated gp240 antigen. The fusion protein containing thioredoxin and a hexa-histidine tag was expressed in two Escherichia coli host cells, AD494 (DE3) pLysS and T7 Express I (q). The cell growth and expression level of target protein, His-tagged scFvMEL/TNF, were highly dependent on the induction temperature, inducer types and host strains. The ratio of insoluble to soluble target proteins was found to be controllable and could be minimized using cold shock conditions at less than 18 degrees C. The total productivity of soluble target protein was further improved by high cell density cultivation using a DO-STAT feeding strategy. The scFvMEL/TNF purified under their conditions was specifically cytotoxic to gp240-antigen positive melanoma A375-M cells as previously described.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703297     DOI: 10.1007/s00253-007-1133-3

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

1.  The Effects of Lactose Induction on a Plasmid-Free E. coli T7 Expression System.

Authors:  Johanna Hausjell; Regina Kutscha; Jeannine D Gesson; Daniela Reinisch; Oliver Spadiut
Journal:  Bioengineering (Basel)       Date:  2020-01-06

2.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

3.  Characterization of a single-chain variable fragment recognizing a linear epitope of aβ: a biotechnical tool for studies on Alzheimer's disease?

Authors:  Silke Dornieden; Andreas Müller-Schiffmann; Heinrich Sticht; Nan Jiang; Yeliz Cinar; Michael Wördehoff; Carsten Korth; Susanne Aileen Funke; Dieter Willbold
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.